Literature DB >> 15013881

Ocular vaccinia following exposure to a smallpox vaccinee.

Gang Hu1, Marcus J Wang, Marjorie J Miller, Gary N Holland, David A Bruckner, Rachel Civen, Lee A Bornstein, Laurene Mascola, Michael A Lovett, Bartly J Mondino, David A Pegues.   

Abstract

PURPOSE: To describe the presentation and management of the first identified case of ocular vaccinia infection associated with the current smallpox vaccination program.
DESIGN: Case report.
METHODS: Vaccinia virus was isolated by cell culture of a conjunctival swab. Direct staining with fluorescein isothiocyanate-labeled vaccinia antibody and polymerase chain reaction testing confirmed the diagnosis.
RESULTS: In February 2003, a 26-year-old woman developed right preseptal cellulitis and blepharoconjunctivitis following contact with a vaccinated member of the military. The preseptal cellulitis resolved with antibacterial therapy, and the conjunctival infection was treated successfully with a 14-day course of topical trifluridine and a single dose of intravenous vaccinia immune globulin.
CONCLUSIONS: To facilitate rapid diagnosis and appropriate treatment, clinicians must maintain a high index of suspicion for ocular smallpox vaccine-associated adverse reactions in vaccine recipients and their close contacts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013881     DOI: 10.1016/j.ajo.2003.09.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

Review 1.  [Adverse ocular effects of vaccinations].

Authors:  T Ness; H Hengel
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  Comparison of methods for detection of vaccinia virus in patient specimens.

Authors:  Daniel P Fedorko; Jeanne C Preuss; Gary A Fahle; Li Li; Steven H Fischer; Patricia Hohman; Jeffrey I Cohen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Treatment of viral conjunctivitis with antiviral drugs.

Authors:  Chrysanthi L Skevaki; Ioanna E Galani; Michail V Pararas; Konstantina P Giannopoulou; Athanassios Tsakris
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

4.  LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.

Authors:  Masayuki Saijo; Yasushi Ami; Yuriko Suzaki; Noriyo Nagata; Naoko Iwata; Hideki Hasegawa; Momoko Ogata; Shuetsu Fukushi; Tetsuya Mizutani; Tetsutaro Sata; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 5.  Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research.

Authors:  Mary G Reynolds; Andrea M McCollum; Beatrice Nguete; Robert Shongo Lushima; Brett W Petersen
Journal:  Viruses       Date:  2017-12-12       Impact factor: 5.048

6.  Ocular Vaccinia Infection in Dairy Worker, Brazil.

Authors:  Maurício Teixeira Lima; Graziele Pereira Oliveira; Felipe Lopes Assis; Danilo Bretas de Oliveira; Sidiner Mesquita Vaz; Giliane de Souza Trindade; Jônatas Santos Abrahão; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.